Takamitsu Nakano

5.0k total citations
50 papers, 2.2k citations indexed

About

Takamitsu Nakano is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Takamitsu Nakano has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 19 papers in Cancer Research. Recurrent topics in Takamitsu Nakano's work include Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers) and Cancer, Lipids, and Metabolism (19 papers). Takamitsu Nakano is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers) and Cancer, Lipids, and Metabolism (19 papers). Takamitsu Nakano collaborates with scholars based in Japan, United States and Canada. Takamitsu Nakano's co-authors include Katsuyuki Nakajima, Akira Tanaka, Masakazu Adachi, Motoko Suzuki, Aki Tamura, Toshimitsu SAITO, Norio Tada, Richard J. Havel, Elisa Campos and Peter J. Havel and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and FEBS Letters.

In The Last Decade

Takamitsu Nakano

50 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takamitsu Nakano Japan 23 1.3k 848 710 546 411 50 2.2k
Esther Ooi Australia 28 937 0.7× 1.1k 1.3× 539 0.8× 362 0.7× 431 1.0× 81 2.2k
Thomas P. Bersot United States 30 1.4k 1.1× 1.2k 1.4× 499 0.7× 581 1.1× 514 1.3× 43 2.6k
Hans Jansen Netherlands 27 1.1k 0.8× 853 1.0× 707 1.0× 299 0.5× 277 0.7× 60 2.0k
J L Jenner United States 21 1.6k 1.2× 1.9k 2.2× 736 1.0× 627 1.1× 357 0.9× 25 3.1k
Angelo B. Cefalù Italy 26 896 0.7× 1.1k 1.3× 864 1.2× 384 0.7× 370 0.9× 129 2.5k
Masumi Ai Japan 24 962 0.7× 850 1.0× 386 0.5× 296 0.5× 314 0.8× 68 1.8k
T Kuusi Finland 30 1.7k 1.3× 1.1k 1.3× 572 0.8× 354 0.6× 333 0.8× 49 2.7k
Melissa A. Austin United States 10 1.2k 0.9× 984 1.2× 432 0.6× 302 0.6× 270 0.7× 10 1.9k
Katalin V. Horvath United States 25 1.5k 1.2× 1.6k 1.9× 452 0.6× 544 1.0× 263 0.6× 47 2.5k
Dorothy Bedford United Kingdom 22 1.2k 0.9× 875 1.0× 594 0.8× 318 0.6× 417 1.0× 35 2.0k

Countries citing papers authored by Takamitsu Nakano

Since Specialization
Citations

This map shows the geographic impact of Takamitsu Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takamitsu Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takamitsu Nakano more than expected).

Fields of papers citing papers by Takamitsu Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takamitsu Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takamitsu Nakano. The network helps show where Takamitsu Nakano may publish in the future.

Co-authorship network of co-authors of Takamitsu Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Takamitsu Nakano. A scholar is included among the top collaborators of Takamitsu Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takamitsu Nakano. Takamitsu Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawashiri, Masa‐aki, Hayato Tada, Matsuo Taniyama, et al.. (2015). Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia. JIMD Reports. 22. 85–94. 11 indexed citations
2.
Shimomura, Younosuke, Yukio Ando, Isao Kobayashi, et al.. (2013). Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 51(1). 68–79. 8 indexed citations
3.
Imagawa, Michiko, Sadao Takahashi, Yasuo Zenimaru, et al.. (2011). Comparative reactivity of remnant-like lipoprotein particles (RLP) and low-density lipoprotein (LDL) to LDL receptor and VLDL receptor: Effect of a high-dose statin on VLDL receptor expression. Clinica Chimica Acta. 413(3-4). 441–447. 12 indexed citations
4.
Sekine, Yoshitaka, Hidekazu Koike, Takamitsu Nakano, et al.. (2009). Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor. Cancer Epidemiology. 33(1). 16–23. 28 indexed citations
5.
Nakajima, Katsuyuki, Takamitsu Nakano, Takeaki Nagamine, et al.. (2009). The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers. Clinica Chimica Acta. 404(2). 124–127. 30 indexed citations
6.
Miwa, Kenji, Akihiro Inazu, Masa‐aki Kawashiri, et al.. (2008). Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients. Clinica Chimica Acta. 402(1-2). 19–24. 18 indexed citations
7.
Sekine, Yoshitaka, Hidekazu Koike, Takamitsu Nakano, Katsuyuki Nakajima, & Kazuhiro Suzuki. (2007). Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells. Clinica Chimica Acta. 383(1-2). 78–84. 24 indexed citations
8.
Nakajima, Y., Sanae Takeichi, Motoki Osawa, et al.. (2006). The lipid and lipoprotein profiles of apo B-carrying particles in remnant-like lipoproteins isolated from plasma in sudden cardiac death cases.. PubMed. 31(4). 160–6. 2 indexed citations
9.
Okamoto, Hiroshi, Tomohiko Sasase, Noboru Furukawa, et al.. (2006). Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma. Clinica Chimica Acta. 375(1-2). 92–98. 19 indexed citations
10.
Yamazaki, Masako, Shinichiro Uchiyama, Yun Xiong, et al.. (2004). Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents. Thrombosis Research. 115(3). 211–218. 22 indexed citations
11.
Usui, Shinichi, Kazuhiro Suzuki, Hidetoshi Yamanaka, et al.. (2002). Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques. Clinica Chimica Acta. 317(1-2). 133–143. 21 indexed citations
12.
Takeichi, Sanae, Y. Nakajima, Nobuhiro Yukawa, et al.. (2001). Plasma triglyceride-rich lipoprotein remnants as a risk factor of ‘Pokkuri disease’. Legal Medicine. 3(2). 84–94. 22 indexed citations
13.
Okazaki, Mitsuyo, Shinichi Usui, Norio Tada, Takamitsu Nakano, & Katsuyuki Nakajima. (2000). Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clinica Chimica Acta. 296(1-2). 135–149. 38 indexed citations
14.
Kawakami, Akio, Akira Tanaka, Takamitsu Nakano, Katsuyuki Nakajima, & Fujío Numano. (2000). The Role of Remnant Lipoproteins in Atherosclerosis. Annals of the New York Academy of Sciences. 902(1). 352–356. 1 indexed citations
15.
Takeichi, Sanae, Nobuhiro Yukawa, Y. Nakajima, et al.. (1999). Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis. 142(2). 309–315. 73 indexed citations
16.
Nakano, Takamitsu, et al.. (1995). [Remnant-like particles-cholesterol (RLP-C) assay and its clinical application to lipid tests in a postprandial as well as fasting state].. PubMed. 43(11). 1159–67. 12 indexed citations
17.
Nakajima, Katsuyuki, Toshimitsu SAITO, Aki Tamura, et al.. (1993). Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clinica Chimica Acta. 223(1-2). 53–71. 373 indexed citations
18.
Hidaka, Hideki, Hideto Kojima, Takahiko Aoki, et al.. (1990). Apolipoprotein B-48 analysis by high-performance liquid chromatography in VLDL: a sensitive and rapid method. Clinica Chimica Acta. 189(3). 287–296. 9 indexed citations
19.
Tamura, Akira, Keiji Kanda, Tatsuzo Fujii, et al.. (1988). Abnormalities in the Membrane of Erythrocytes from Two Patients Homozygous for Familial Hypobetalipoproteinemia. Journal of Clinical Biochemistry and Nutrition. 5(2). 103–109. 4 indexed citations
20.
Kojima, Hideto, Yutaka Harano, Keisuke Kosugi, Takamitsu Nakano, & Yukio Shigeta. (1986). A suppressive role of c‐kinase for the stimulation of hepatic ketogenesis by glucagon and epinephrine. FEBS Letters. 201(2). 271–276. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026